Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy. Furneri G, Santoni L, Marchesi C, Iannazzo S, Cortesi P, Piacentini P, Caputi A, Mantovani LG Value Health. 2015 Nov; 18(7):A697. Epub 2015 Oct 20. PMID: 26533908. Abstract CommentRecommendBookmarkWatch